Hussein Kanji
Partner @ Hoxton Ventures
London, United Kingdom
Hussein Kanji is a seed investor at Hoxton Ventures in London focused on Software and Artificial Intelligence. Hussein Kanji PartnerA proud New Yorker, Hussein is the founder of Hoxton and one of Europe’s most influential tech investors, appearing on Forbes’ Midas List Europe in 2023 and VCJ's Hot Prospects in 2010. His career has included senior roles at Microsoft and over a decade in Silicon Valley’s startup ecosystem. He holds an MBA from LondonBusiness School and did his undergraduate studies in Symbolic Systems at Stanford University.
- Total investments:
- 55
- Last investment:
- Lead investor:
- 47%
Last updated:
For AI agents: llms.txt
Industries Hussein Kanji invests in
Stages Hussein Kanji invests in
Countries Hussein Kanji invests in
Round sizes
Round size
- Seed
- $2.3M–$8.4M
- Series A
- $2.2M–$18M
- Series B
- $5M–$20M
Investment Focus
Industry
- Software 9 (16%)
- Artificial Intelligence 9 (16%)
- Information Technology 8 (15%)
- SaaS 7 (13%)
- Machine Learning 6 (11%)
Stage
- Seed 18 (33%)
- Series A 18 (33%)
- Series B 7 (13%)
- Series C 4 (7%)
- Venture - Series Unknown 2 (4%)
Country
- United Kingdom 26 (47%)
- United States 6 (11%)
- India 1 (2%)
- Austria 1 (2%)
- Germany 1 (2%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Behavox
|
Behavox is an enterprise platform that unifies all types of data into a single data lake, allowing users to query the data and apply machine learning to identify capital markets misconduct and insider threats.Separate Behavox installations form the network defence that aggregates misconduct detection algorithms. The network then uses machinelearning and AI to optimise detection algorithms and suggest new ones. This innovation enables the “brains” to the system to continuously improve and evolve.Complex, high-load and sophisticated engineering is at the core of all the products that Behavox develops to enable deployment at the largest institutions in financial services. They are taking cutting-edge academic research and applying it to enterprise problems that require complex backend engineering with large-scale production footprint. | $173.2M / Private Equity / Jun 17, 2026 | |
Giraffe360
|
Giraffe360 is game-changing subscription product for real estate companies to streamline professional quality photography and high accuracy floor plan creation. | $10M / Series B / Mar 26, 2026 | |
Milvus Advanced
|
Milvus Advanced is a chemical company that develops cutting-edge nanoalloys as substitutes for high-value metals crucial to decarbonisation. | $6.9M / Seed / Oct 20, 2025 | |
Finster AI
|
Finster AI offers AI agents that can read, analyse and integrate disparate sources of financial and market data. | $10M / Series A / Oct 20, 2025 | |
Druid AI
|
DRUID is a high-tech company that develops an AI-powered, no-code, chatbot authoring platform that allows citizen developers to create, configure and deploy natural and rich interactions between employees, customers, partners, and enterprise systems, through omnichannel text and voice conversations. The platform features a proprietarymulti-language NLU (Natural Language Understanding) engine which identifies user intents, sentiment, and system entities, a powerful Connector Designer which integrates with any enterprise app (REST/SOAP APIs, SQL/Oracle, ERPs, CRMs, RPA). | $31M / Series C / Sep 16, 2025 | |
EVERBLOOM
|
Bloomlabs provides a method to catalyze waste value by regenerating it as adaptable and appealing bio-plastics and textile fibers. It envisions a future in which outmoded, resource-intensive processes are phased out in favor of cutting-edge, sustainable, and scalable alternatives. | $7.5M / Seed / Aug 19, 2025 | |
|
Finster AI
|
Finster AI offers AI agents that can read, analyse and integrate disparate sources of financial and market data. | $5.1M / Seed / Jan 02, 2025 | |
Cogna
|
Cogna offers an AI-powered SaaS platform that streamlines the integration of data across several business domains. | $16.1M / Series A / Nov 11, 2024 | |
Baseimmune
|
Baseimmune is a biotech startup founded to create the next generation of vaccines. | $11.4M / Series A / Feb 26, 2024 | |
BioCorteX
|
BioCorteX is a pharmaceutical company specializing in enhanced therapeutics to cure neurodegenerative diseases using microorganisms. | $5M / Seed / Mar 28, 2023 | |
| See all 55 investments → | |||
Co-Investors
About Hoxton Ventures
Hoxton Ventures focuses on startups that either disrupt existing industries or invent entirely new market categories. Hoxton typically invests between $500,000 and $5 million into pre-seed, seed, and Series A stage companies, and follows its capital through the life of the company. The firm is based in London and invests all across Europe.
Hoxton Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Hussein Kanji
Partner
|
|||
Bryan Gartner
Partner
|
|||
|
Dahlia Jacobs
Finance Director
|
|||
Isabel Fox
Head of IR
|
|||
Mandeep Singh
Venture Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Hussein Kanji invest in?
Hussein Kanji invests primarily in Software, Artificial Intelligence and Information Technology startups, most often at Seed and Series A stage. Most of the 55 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Hussein Kanji's check size?
Hussein Kanji typically joins rounds of $2.3M–$8.4M at Seed, $2.2M–$18M at Series A and $5M–$20M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Hussein Kanji participates in.
When did Hussein Kanji last invest?
The most recent investment recorded for Hussein Kanji closed in Jun 2026. Shizune tracks 55 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
